Back to GetFilings.com



Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended December 31, 2002

 

Commission File Number 001-11091

 


 

APOGENT TECHNOLOGIES INC.

(Exact name of Registrant as specified in its charter)

 

Wisconsin

 

22-2849508

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. employer

identification no.)

 

30 Penhallow Street, Portsmouth, New Hampshire 03801

(Address of principal executive offices, including zip code)

 

(603) 433-6131

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨  No  x

 

At January 31, 2003, there were 105,199,912 shares of the Registrant’s Common Stock, par value $0.01 per share, outstanding.

 



Table of Contents

 

APOGENT TECHNOLOGIES INC. AND SUBSIDIARIES

FORM 10-Q

QUARTER ENDED DECEMBER 31, 2002

 

TABLE OF CONTENTS

 

         

Page


PART I—FINANCIAL INFORMATION

    

Item 1:

  

Financial Statements

    
    

Consolidated Balance Sheets as of December 31, 2002 (unaudited) and September 30, 2002

  

1

    

Consolidated Statements of Income for the Three Months Ended December 31, 2002 and 2001 (unaudited)

  

2

    

Consolidated Statement of Stockholders’ Equity for the Three Months Ended December 31, 2002 (unaudited)

  

3

    

Consolidated Statements of Cash Flows for the Three Months Ended December 31, 2002 and 2001 (unaudited)

  

4

    

Notes to Unaudited Consolidated Financial Statements

  

5

Item 2:

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

17

    

Cautionary Factors

  

25

Item 3:

  

Quantitative and Qualitative Disclosures About Market Risk

  

29

Item 4:

  

Controls and Procedures

  

29

PART II—OTHER INFORMATION

    

Item 4:

  

Submission of Matters to a Vote of Security Holders

  

29

Item 5:

  

Other Information

  

30

Item 6:

  

Exhibits and Reports on Form 8-K

  

30

    

Signature

  

30

    

Certifications

  

31

    

Exhibit Index

  

33

 


Table of Contents

 

PART I—FINANCIAL INFORMATION

 

Item 1: Financial Statements

 

APOGENT TECHNOLOGIES INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(In thousands, except share and per share data)

 

    

December 31, 2002


    

September 30, 2002


 
    

(unaudited)

        

Assets

                 

Current assets:

                 

Cash and cash equivalents

  

$

15,755

 

  

$

16,327

 

Accounts receivable (less allowance for doubtful accounts of $4,940 and $5,723, respectively)

  

 

170,068

 

  

 

186,950

 

Inventories

  

 

219,582

 

  

 

203,997

 

Deferred income taxes

  

 

14,127

 

  

 

14,127

 

Prepaid expenses and other current assets

  

 

19,502

 

  

 

19,689

 

Assets of Vacuum Process Technology, Inc. (“VPT”) avail. for sale

  

 

5,880

 

  

 

5,436

 

    


  


Total current assets

  

 

444,914

 

  

 

446,526

 

Available for sale security

  

 

59,592

 

  

 

60,183

 

Property, plant and equipment, net

  

 

272,375

 

  

 

270,893

 

Intangible assets

  

 

1,268,550

 

  

 

1,243,113

 

Other assets

  

 

14,155

 

  

 

15,370

 

    


  


Total assets

  

$

2,059,586

 

  

$

2,036,085

 

    


  


Liabilities and Shareholders' Equity

                 

Current liabilities:

                 

Short-term debt and overdrafts

  

$

13,539

 

  

$

10,640

 

Accounts payable

  

 

46,566

 

  

 

53,779

 

Current portion of long-term debt

  

 

25,348

 

  

 

25,352

 

Income taxes payable

  

 

50,394

 

  

 

53,064

 

Accrued payroll and employee benefits

  

 

28,271

 

  

 

32,009

 

Accrued interest expense

  

 

8,187

 

  

 

16,630

 

Restructuring reserve

  

 

886

 

  

 

1,548

 

Other current liabilities

  

 

29,195

 

  

 

23,074

 

Liabilities of Vacuum Process Technology, Inc.

  

 

293

 

  

 

305

 

    


  


Total current liabilities

  

 

202,679

 

  

 

216,401

 

Long-term debt

  

 

650,618

 

  

 

635,020

 

Securities lending agreement

  

 

59,592

 

  

 

60,183

 

Deferred income taxes

  

 

134,904

 

  

 

132,100

 

Other liabilities

  

 

17,244

 

  

 

17,243

 

Commitments and contingent liabilities

  

 

—  

 

  

 

—  

 

Shareholders’ equity:

                 

Preferred stock, $0.01 par value; authorized 20,000,000 shares

  

 

—  

 

  

 

—  

 

Common stock, $0.01 par value; authorized 250,000,000 shares issued 106,985,276 and 106,976,877 shares respectively; outstanding 105,139,332 and 105,967,853 shares respectively

  

 

1,070

 

  

 

1,070

 

Equity rights, 50 rights at $1.09 per right

  

 

—  

 

  

 

—  

 

Additional paid-in capital

  

 

272,427

 

  

 

271,682

 

Retained earnings

  

 

777,526

 

  

 

748,791

 

Accumulated other comprehensive income (loss)

  

 

(18,383

)

  

 

(26,419

)

Treasury common stock, 1,845,944 and 1,009,024 shares at cost

  

 

(38,091

)

  

 

(19,986

)

    


  


Total shareholders’ equity

  

 

994,549

 

  

 

975,138

 

    


  


Total liabilities and shareholders' equity

  

$

2,059,586

 

  

$

2,036,085

 

    


  


 

See the accompanying notes to the unaudited consolidated financial statements

 

1


Table of Contents

 

APOGENT TECHNOLOGIES INC. AND SUBSIDIARIES

Consolidated Statements of Income

(In thousands, except per share data)

(Unaudited)

 

    

Three Months Ended December 31,


 
    

2002


    

2001


 

Net sales

  

$

266,537

 

  

$

243,187

 

Cost of sales

  

 

138,064

 

  

 

124,454

 

    


  


Gross profit

  

 

128,473

 

  

 

118,733

 

Selling, general and administrative expenses

  

 

72,151

 

  

 

61,683

 

    


  


Operating income

  

 

56,322

 

  

 

57,050

 

Other income (expense):

                 

Interest expense

  

 

(10,399

)

  

 

(10,232

)

Amortization of deferred financing fees

  

 

(912

)

  

 

(827

)

Other, net

  

 

497

 

  

 

1,476

 

    


  


Income from continuing operations before income taxes

  

 

45,508

 

  

 

47,467

 

Income taxes

  

 

16,610

 

  

 

17,378

 

    


  


Income from continuing operations

  

 

28,898

 

  

 

30,089

 

Discontinued operations (loss from operations of VPT, net of income tax benefit of $89 and $82, respectively)

  

 

(163

)

  

 

(122

)

    


  


Net income

  

$

28,735

 

  

$

29,967

 

    


  


Basic earnings per common share from continuing operations

  

$

0.27

 

  

$

0.28

 

Discontinued operations

  

 

—  

 

  

 

—  

 

    


  


Basic earnings per common share

  

$

0.27

 

  

$

0.28

 

    


  


Diluted earning per common share from continuing operations

  

$

0.27

 

  

$

0.28

 

Discontinued operations

  

 

—  

 

  

 

—  

 

    


  


Diluted earnings per common share

  

$

0.27

 

  

$

0.28

 

    


  


Weighted average basic shares outstanding

  

 

105,719

 

  

 

106,128

 

Weighted average diluted shares outstanding

  

 

107,010

 

  

 

108,949

 

 

See accompanying notes to the unaudited consolidated financial statements.

 

 

2


Table of Contents

 

APOGENT TECHNOLOGIES INC. AND SUBSIDIARIES

Consolidated Statement of Shareholders’ Equity

For the Three Months Ended December 31, 2002

(In thousands)

(Unaudited)

 

    

Common Stock


    

Equity       Rights      


  

Additional Paid-In Capital


  

Retained Earnings


  

Accumulated Other Comprehensive Income


    

Treasury Common Stock


    

Total Shareholders' Equity


 

Balance at September 30, 2002

  

$

1,070

    

$

—  

  

$

271,682

  

$

748,791

  

$

(26,419

)

  

$

(19,986

)

  

$

975,138

 

Comprehensive income:

                                                        

Net income

  

 

—  

    

 

—  

  

 

—  

  

 

28,735

  

 

—  

 

  

 

—